Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11373)
All Articles published online
|
Publishing Process of This Article
|
Mar 31, 2019 (publication date) through Jul 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Meta-Analysis
ISSN
2308-3840
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li J, Zhang XH, Bei SH, Feng L. PD-1/PD-L1 antagonists in gastric cancer: Current studies and perspectives. World J Meta-Anal 2019; 7(3): 101-109 [DOI: 10.13105/wjma.v7.i3.101] |
|---|---|
| URL: | https://www.wjgnet.com/2308-3840/full/v7/i3/101.htm |
| Number | Citing Articles |
| 1 |
Birgid Schoemig-Markiefka, Jana Eschbach, Andreas H. Scheel, Aylin Pamuk, Josef Rueschoff, Thomas Zander, Reinhard Buettner, Wolfgang Schroeder, Christiane J. Bruns, Heike Loeser, Hakan Alakus, Alexander Quaas. Optimized PD-L1 scoring of gastric cancer. Gastric Cancer 2021; 24(5): 1115 doi: 10.1007/s10120-021-01195-4
|
| 2 |
So-Woon Kim, Gowun Jeong, Min-Hee Ryu, Young Soo Park. Comparison of PD-L1 immunohistochemical assays in advanced gastric adenocarcinomas using endoscopic biopsy and paired resected specimens. Pathology 2021; 53(5): 586 doi: 10.1016/j.pathol.2020.10.015
|
| 3 |
Woosook Kim, Timothy H. Chu, Henrik Nienhüser, Zhengyu Jiang, Armando Del Portillo, Helen E. Remotti, Ruth A. White, Yoku Hayakawa, Hiroyuki Tomita, James G. Fox, Charles G. Drake, Timothy C. Wang. PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in Mice. Gastroenterology 2021; 160(3): 781 doi: 10.1053/j.gastro.2020.10.036
|
| 4 |
Ping Zhang, Xiaomeng Zhang, Na Zhu, Feifei Zhuang, Dongmei Zhou, Ping Wang, Hangjun Che. Clinical Efficacy, Survival, and Adverse Reaction Evaluation of Immune Checkpoint Inhibitor in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/6998090
|
| 5 |
Caroline de Fátima Aquino Moreira-Nunes, Cláudia Nazaré de Souza Almeida Titan Martins, Danielle Feio, Isamu Komatsu Lima, Leticia Martins Lamarão, Carolina Rosal Teixeira de Souza, Igor Brasil Costa, Jersey Heitor da Silva Maués, Paulo Cardoso Soares, Paulo Pimentel de Assumpção, Rommel Mário Rodríguez Burbano. PD-L1 Expression Associated with Epstein—Barr Virus Status and Patients’ Survival in a Large Cohort of Gastric Cancer Patients in Northern Brazil. Cancers 2021; 13(13): 3107 doi: 10.3390/cancers13133107
|
| 6 |
Hyun Cheol Chung, Yung-Jue Bang, Charles S Fuchs, Shu-Kui Qin, Taroh Satoh, Kohei Shitara, Josep Tabernero, Eric Van Cutsem, Maria Alsina, Zhu Alexander Cao, Jia Lu, Pooja Bhagia, Chie-Schin Shih, Yelena Y Janjigian. First-Line Pembrolizumab/Placebo Plus Trastuzumab and Chemotherapy in Her2-Positive Advanced Gastric Cancer: KEYNOTE-811. Future Oncology 2021; 17(5): 491 doi: 10.2217/fon-2020-0737
|
| 7 |
Sabina Pozzi, Anna Scomparin, Sahar Israeli Dangoor, Daniel Rodriguez Ajamil, Paula Ofek, Lena Neufeld, Adva Krivitsky, Daniella Vaskovich-Koubi, Ron Kleiner, Pradip Dey, Shani Koshrovski-Michael, Noa Reisman, Ronit Satchi-Fainaro. Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?. Advanced Drug Delivery Reviews 2021; 175: 113760 doi: 10.1016/j.addr.2021.04.001
|